Vyvo
A genuinely FDA-cleared $149 wearable attached to a $718.80-a-year qualification subscription and a $325-to-$3,000 tiered stake that buys a 1x to 4x multiplier on a token pool - a rail the operator announced it was winding down on 24 July 2026.
The hardware is real and the FDA clearance is real - but a $3,000 Data NFT Stake bought a 4x multiplier that a $325 stake did not, funds locked for twelve months, and on 24 July 2026 the operator announced it is shutting the whole rail down without publishing what happens to the money.
Can you actually make money with Vyvo?
No, and the most recent fact is the loudest. On 24 July 2026 the operator announced that the chain, the coin and the Data-NFT business will cease operations through an organized wind-down. That announcement publishes no treatment of staked funds, no redemption, no buy-back, no policy on unpaid distributor commissions, no timeline and no name for the successor entity. Anyone inside the twelve-month lock is exposed to an outcome nobody has written down. A wind-down is a corporate fact rather than misconduct. It is still where the money currently sits.
The stake is the part that needs understanding. A $325 Level 1 stake returned a 1x multiplier on the pooled token distribution and a $3,000 Level 4 stake returned 4x, for the identical physical act of wearing the device and generating the same Health Index score. The extra $2,675 bought no hardware, no function and no additional data. Meanwhile the token has fallen about 99.5% from its December 2023 peak, on global daily volume near $3,587, so a $3,000 position is roughly 84% of a full day of worldwide trading.
The cost side is fully documented and the income side does not exist. A typical builder pays $369 for the starter kit, $20 in setup, $718.80 for twelve months of the subscription that keeps them commission-eligible, and $325 for a Level 1 stake. That is $1,432.80 in year one, of which 73% is recurring subscription and locked capital buying no hardware. No income disclosure of any kind has been published in thirteen years across four brand generations, by a group whose parent is quoted on a US public market.
The device deserves its own paragraph, because it is genuinely real. FDA 510(k) K231288 was decided Substantially Equivalent on 4 March 2024 - the actual Class II premarket notification route, not a facility registration and not a device listing. At $149 the band matches the Amazfit Helio Ring almost to the dollar and undercuts the Oura Ring 4 at $349 plus $5.99 a month, and basic function needs no subscription at all. Somebody could want that hardware with no income offer anywhere near it.
device from $149 plus a $20 setup fee, then $59.90 a month to stay commission-eligible; Data NFT Stakes sold separately at $15 to $3,000 with a twelve-month lock
- Publish what happens to the staked funds. The 24 July 2026 announcement names no redemption terms, no buy-back, no timeline and no entity, and the twelve-month lock has no documented early exit at any penalty.
- One income disclosure, after thirteen years and four brands. The trade site that exists to publish top-earner figures carries this company's as "N/A", for a business it estimates at $70 million a year.
- Stop selling the multiplier. Paying 4x on a $3,000 stake and 1x on a $325 one for the same readings makes the return a function of capital placed rather than of anything the wearer did.
- An affiliate agreement that names the actual counterparty and covers the actual instrument. The only one reachable without a login names the predecessor brand, is governed by the laws of India, and never mentions tokens or NFTs.
That call is computed, not chosen - the rule reads three of the nine published dimension scores and is printed on the methodology page. It describes this company's plan and the figures it publishes about the people already in it. It is not a prediction about you, and nothing on this site is advice.
Legal status
LEGAL - and the regulatory sheet is cleaner than the file otherwise reads, which must be said plainly. No securities-regulator warning, alert, advisory, cease-and-desist or enforcement action against Vyvo, Vyvo Smart Chain, inPersona, Helo Corp or the predecessor World Global Network could be located in any jurisdiction searched: Belgium FSMA, Italy CONSOB, Spain CNMV, France AMF, the Canadian commissions, New Zealand FMA, the Philippines SEC, US state securities regulators and the US SEC. No FTC enforcement action. No court case, no class action, no criminal proceeding. The only formal item on file is a Direct Selling Self-Regulatory Council referral of Vyvo, Inc. to the Federal Trade Commission on 1 September 2022 over unsubstantiated earnings claims - and a self-regulatory body referring a non-responsive member is not an FTC investigation, not a complaint and not a finding of liability; no FTC docket following it could be located. The 24 July 2026 wind-down is a corporate restructuring announcement, not a finding of wrongdoing. What this report describes about the Data NFT Stake is the mechanics of the instrument, not a legal characterisation: no regulator and no court anywhere has ruled on it.
Confidence: Medium
Primary sources fetched directly where possible. Everything we could not verify is listed at the bottom of this page by name.
Follow the money
A wearable business sold through a referral network, with three layers stacked on top of each other. The bottom layer is hardware - a BioSense Band or BioSense Ring at $149, with a DNA kit, stickers and a larger device in the catalog. The middle layer is a SmartLife Solution app subscription at $9.90, $59.90 or $99.90 a month, where the middle tier is what actually qualifies you to be paid. The top layer, from 2023, was inPersona and the Vyvo Smart Chain: Data NFT Stakes bought at $15 to $3,000 which multiplied a share of a token reward pool by 1x, 2x, 3x or 4x according to what you paid.
Start with what is genuinely good, because it is genuinely good. The FDA clearance is real and verifiable: 510(k) K231288, applicant Vyvo Technology Corp. of Miami, decided Substantially Equivalent on 4 March 2024, product code DQA under 21 CFR 870.2700. That is the real Class II pathway, not a registration or a listing, and most programs in this space that talk about the FDA do not have one. The hardware is competitively priced - $149 matches a mainstream smart ring almost to the dollar and undercuts the category benchmark by $200. No securities-regulator warning, alert, advisory or order could be located in any jurisdiction searched, and no FTC action, court case or class action was found in any forum. The whitepaper promises no yield, and the company states in its own documentation that it does not set the token price and the market does. All of that is real and all of it counts.
Then the precision that has to travel with the clearance. Product code DQA covers pulse oximetry only. It does not cover ECG, cuffless blood pressure, atrial-fibrillation detection or bioelectrical impedance - all of which are marketed across the range, with the band page describing a "medical-grade fingertip sensor measuring blood pressure, oxygen levels (SPO2), and arterial conditions (APG)." A clearance for one indication is not approval of every claim the marketing makes, and the May 2024 press release headline "Vyvo Achieves FDA Approval for Wearable Devices" states a regulatory status the company does not hold, even though the body text of the same release says clearance.
The participant economics are documented on the cost side and absent on the income side. A typical builder pays $369 for the Smart Kit, $20 setup, $718.80 a year for the Loyalty subscription that keeps them commission-eligible, and $325 for a Level 1 Data NFT Stake: $1,432.80 in year one, 73% of it subscription and locked capital. Against that there is no income disclosure statement - none has ever been published, in thirteen years, across four brand generations, by a group whose parent is quoted on a US public market. The direct-selling trade site that specializes in publishing top-earner incomes lists this company’s figures as "N/A."
And then the thing that happened seven days before this review was published. On 24 July 2026 the group announced that Vyvo Smart Chain, VSC Coin and the inPersona Data-NFT business "will cease operations through an organized wind-down process," that the SocialFi, AI and accessories divisions will be spun into a new independent entity, and that the group will refocus on GPU management infrastructure. The announcement does not say what happens to staked funds, whether VSC holders can redeem anything, what becomes of unpaid distributor commissions, what the timeline is, or who owns the spin-off. A wind-down is not a finding of wrongdoing and nothing here suggests otherwise. It is a fact about where the locked money currently sits - and for anyone inside a twelve-month lock, it is the only fact that matters.
Where a dollar of participant spend is modeled to go
This is a model, not a company disclosure - Vyvo publishes no payout breakdown of any kind. One input is sourced: the 40% field-commission share, roughly $28 million a year, is a direct-selling trade publication’s estimate rather than a company figure. The remaining five lines are modeled from the group’s filed financials and normal hardware-network cost structure and are unverified.
| Product | Price | Pays |
|---|---|---|
| BioSense Health Band The core device, sold through the Helo Health store. Includes activation and a payment card whose integrated payment function is disabled. Priced at or below comparable consumer smart rings such as the Amazfit Helio Ring and the RingConn Gen 2, and covered by the K231288 oximetry clearance. |
$149.00 one-time |
10% ($14.90) |
| BioSense Ring Titanium and resin, 2.7mm, 3g, IP68, five to seven day battery, charging cable included. The July 2024 launch release marketed blood-pressure monitoring and made no FDA or CE claim at all. |
$149.00 one-time |
10% ($14.90) |
| SmartLife Solution Loyalty subscription The qualification toll - $718.80 a year. This or the $99.90 Pro tier, or six referred customers on $9.90 Light subscriptions, is what keeps you eligible to be paid residuals. The $9.90 Light tier does not qualify you on its own. |
$59.90/month monthly |
10% ($5.99/mo) |
| Vyvo Smart Kit (affiliate starter) DNA kit, one month of supplement subscription and a $200 band voucher. Plus a $20 setup fee. Pricing is 2020-era from the best available public extraction; current pricing could not be confirmed. |
$369.00 one-time |
10% ($36.90) |
| Vyvo Smart Builder Pack Personal kit plus inventory. The largest entry pack documented. Inventory bought at this level was bought for a plan the group has now announced it is exiting. |
$1,499.00 one-time |
10% ($149.90) |
| SmartLife DNA Kit Genetic test processed through a Hong Kong lab whose domain is registered to the founder, plus a nutrition profile. Undelivered DNA reports were among the member complaints recorded under the predecessor brand. |
$249.00 one-time |
10% ($24.90) |
| BioZen Stickers (five-pack) $47.20 per sticker. No clearance, no marking and no independent evidence for this item was located in any source reviewed. |
$236.00 one-time |
10% ($23.60) |
| Data NFT Stake Not a product. It buys a 1x, 2x, 3x or 4x multiplier on a pooled token distribution for identical activity, with funds locked for twelve months from activation or upgrade and no documented early exit. Minting a Data-NFT is stated in the whitepaper to cost up to 35% of the equivalent token value. |
$15 / $325 / $1,000 / $2,000 / $3,000 one-time, twelve-month lock |
no product commission |
Who runs it, and what they ran before
The continuity across every version of this business since 2013. He was President of World Global Network, the predecessor that marketed the Helo wellness band with forthcoming blood-glucose, blood-alcohol and fertility monitoring and a "mosquito shield" - none of which materialised. That brand generated Better Business Bureau complaints, to which the company replied, plus member reports of unpaid commissions and undelivered DNA reports, and a Colombian Change.org petition naming him. A petition is participant sentiment and a BBB posting is a private ratings body: neither is a regulatory or judicial finding, and no regulator action against him or against World Global Network could be located anywhere. In October 2018 he gave a trade-press interview headlined as speaking out about "recent distractions" - the company was publicly managing reputation at that point. He signed the 24 July 2026 wind-down announcement.
Holds 3,731,244 common shares (4.3%) but also 16 of the only 100 Preferred A super-voting shares in existence, and 320,000 Preferred B. So voting control of the public shell and the founder economic interest sit in different hands - Galdi holds the largest common block, McVeigh holds the super-voting instrument. A participant reading "publicly traded" should understand that the control structure is not the ordinary one-share-one-vote arrangement that phrase implies.
Listed alongside director Alessandro Senatore (7,814,125 shares, 9.0%) in the FY2023 Pink Basic Disclosure. Between them the three largest named holders control roughly 38.8% of the common. No regulatory action, fraud judgment or criminal proceeding against any of them could be located in any source reviewed, and that should be stated as clearly as the rest.
Global Mobile Network in 2013 sold VOIP through an MLM structure with "Power Units." That became Wor(l)d Global Network / World Global Network in 2016-17, selling the Helo band. That was rebranded Vyvo in 2019. In Q4 2022 Helo Corp announced plans to abandon the Vyvo MLM opportunity, and the reward machinery migrated to Vyvo Smart Chain and inPersona with Data-NFT Stakes. On 24 July 2026 that was announced as winding down, with the group refocusing on GPU management infrastructure and spinning the SocialFi, AI and accessories divisions into an unnamed new entity. At each transition the participants who had bought the previous thing were left holding it. No public record of any compensation to any prior-brand cohort at any of the four transitions could be located - if such compensation exists it is not public.
Registered address
Miami, Florida, USA - with operating entities in Singapore, Utah and Nevada
There is no single "Vyvo" a participant contracts with. The FDA 510(k) applicant of record is Vyvo Technology Corp. of 123 NW 23rd St., Miami. The direct-selling entities are Vyvo Pte Ltd (Singapore) and Vyvo USA Corp (Utah). The token side sits with Vyvo Foundation (Singapore). The publicly quoted parent is Helo Corp., an OTC Pink quotation in Nevada - which means Pink Basic Disclosure Guidelines, self-published and not SEC-reviewed, rather than a Nasdaq or NYSE listing. The January 2021 transaction was distributed on newswires under a headline carried in Nasdaq press-release feeds, and distributors have used that URL as though it implied a Nasdaq listing. It does not. Only Helo Corp. files anything: the Singapore and Utah operating companies do not publish, so no consolidated group revenue exists in public. Helo Corp. filed continuing-operations revenue of $4,553,764 for the year ended 31 December 2023 against a net income of $8,783,435, which is arithmetically impossible from operations and must be a non-cash or one-off gain; the note breakdown could not be obtained.
The veteran's checklist
Eight questions that decide whether this is a business or a transfer mechanism. Same eight, every review.
| Question | Answer |
|---|---|
| Who legally owns it? |
WATCH
A multi-entity group: Vyvo Technology Corp. (Miami) holds the FDA clearance, Vyvo Pte Ltd (Singapore) and Vyvo USA Corp (Utah) do the direct selling, Vyvo Foundation (Singapore) sits on the token side, and Helo Corp. (OTC Pink: HLOC, Nevada) is the quoted parent. Only Helo Corp. files anything, so no consolidated group revenue exists in public.
|
| What does it really cost? |
CONCERN
$149 for the device plus $20 setup at the low end; a typical builder pays $1,432.80 in year one - $369 kit, $718.80 of Loyalty subscription to stay commission-eligible, and a $325 Level 1 Data NFT Stake. 73% of that buys no hardware.
|
| Published income disclosure? |
RED
None. Not in thirteen years, not across four brand generations, not from a group whose parent is quoted on a US public market. The trade site that publishes MLM top-earner incomes lists this company’s figures as "N/A."
|
| Is the FDA clearance real? |
OK
Yes - 510(k) K231288, Vyvo Technology Corp., Substantially Equivalent on 4 March 2024, product code DQA, 21 CFR 870.2700. It covers pulse oximetry only, not ECG, blood pressure, AFib or bioelectrical impedance, and a clearance is not an approval however the May 2024 headline put it.
|
| Any regulator action anywhere? |
OK
None located, in any jurisdiction searched - no warning listing, alert, advisory, cease-and-desist or enforcement action, no FTC action, no court case, no class action. The only formal item is a self-regulatory referral to the FTC on 1 September 2022, which is not an FTC action and produced no locatable docket.
|
| What is the Data NFT Stake, mechanically? |
RED
$15 to $3,000, funds locked twelve months from activation, delivering a 1x, 2x, 3x or 4x multiplier on a pooled token distribution for identical activity. No contractual document governing it could be located and the affiliate agreement does not mention tokens or NFTs at all.
|
| Can you get your money back? |
RED
Refunds run to ten days from activation on product. On staked funds there is no documented early exit at any penalty - and since 24 July 2026 the operator has announced the rail is winding down without publishing any redemption, buy-back or timeline.
|
| Merchant play or miner play? |
CONCERN
Miner, with an unusually good product attached. The 10% fast start pays the same on a recruit as on a customer, the 25% residual uplift for twelve months is triggered by recruiting, and the binary pays on the weaker leg - but the $149 device is genuinely saleable to someone who will never join anything.
|
What has to be true for you to get paid
| To cover | You need |
|---|---|
| Recover a typical builder year-one outlay by selling devices | 97 device sales in twelve months $1,432.80 at $14.90 of fast-start per $149 band - about two a week, every week, with no repeat purchase |
| Cover the running cost from recurring subscriptions | 21 subscribers maintained continuously $119.90/month of subscription plus amortised entry, at $5.99 a month per Loyalty customer |
| Recover a $2,000 Level 3 stake from token rewards | tokens worth $2,149 that are actually sellable against $3,587 of global daily volume, a 99.5% drawdown from the December 2023 peak and an announced wind-down |
| Reach the rank where the plan genuinely pays | Diamond, held four consecutive weeks $1,000 car bonus plus up to 20% on weaker-leg volume - but the qualification volumes and the weekly cap are both unpublished |
Read this twice
Every number on the cost side of this arithmetic is published and every number on the income side is not, which is the single most important structural fact in the report. The typical-builder entry is $369 for the Smart Kit, $20 setup, $59.90 a month for the Loyalty subscription that maintains eligibility and $325 for a Level 1 Data NFT Stake - $1,432.80 in the first twelve months, of which $1,043.80 buys no hardware. Against that, the fast-start rate is 10%, so a $149 band returns $14.90 and clearing the entry requires ninety-seven of them inside a year, roughly two a week without pause, into a category where the purchase is essentially one-off and there is no consumable to re-order. The subscription route is more plausible on paper: twenty-one continuously active Loyalty customers at $5.99 a month covers the running cost. It is also the route most exposed to churn, on a $59.90-a-month wellness app. Token rewards are valued at zero throughout this exercise and that needs justifying rather than asserting: the token is 99.5% below its December 2023 peak of $0.07558, global daily volume is around $3,587 with roughly $2,160 of it on one venue, a $3,000 position is about 84% of a full day’s worldwide trading, and on 24 July 2026 the operator announced the rail is winding down with no published redemption. Two honest caveats cut the other way. The binary genuinely does pay - up to 20% on weaker-leg volume, plus a 10% level-one match and a $1,000 car bonus at Diamond - so a participant who builds two productive legs can earn meaningfully. And the twelve-month lock has no documented early exit at any penalty, so the Data NFT cost is not recoverable partway through even in principle. What cannot be done is to say how many people reach Diamond, because the rank qualification volumes are unpublished, the weekly binary cap is unpublished, and no income disclosure has ever existed.
Run your own numbers
Drag the sliders. Nothing here is stored or sent.
The Fast Start bonus pays 10% on product and subscription sales, so the $369 Vyvo Smart Kit is worth about $36.90 to the person who sells it - and the plan pays that same 10% whether the buyer is a retail customer or a new recruit, which is the central structural fact in the report. Cost is the $59.90-a-month Loyalty subscription that keeps you eligible to be paid at all; the alternative to paying it yourself is finding six people on the $9.90 Light plan, which the plan treats as equivalent. Modeled as one-off because the kit sale is the dominant number: the roughly $5.99 a month of Fast Start on a retained subscription is excluded, as are the binary cycles, because those depend on an organization rather than on anything you sell. Two things the model deliberately does not include. The Data NFT Stakes at $325 to $3,000, with a twelve-month lock and a 1× to 4× multiplier on a pooled token distribution, are not a commission and are not modeled as one. And on 24 July 2026 the operator announced a wind-down of the chain, the app and the smart-chain rail with no published treatment of staked funds, so every token-side figure a recruiter may quote should be treated as unresolved. No income disclosure has been published in thirteen years across four brands. Your own subscription cost of $59.9/mo is included.
What it costs to replace this yourself
What the same health-tracking capability costs on the open market, using ordinary consumer wearables at their published retail prices. This is the fairest exercise in the report and it does not go the way the rest of the file does - on hardware alone Vyvo is competitive. The gap opens entirely on the things attached to the hardware.
| What they sell you | What you'd use instead | Your cost |
|---|---|---|
| BioSense Ring - $149.00 | Amazfit Helio Ring - comparable sensor set, no subscription | $149.99 |
| BioSense Health Band - $149.00 | Xiaomi Smart Band 9 / Fitbit Inspire 3 / Garmin vivofit 4 class | sub-$100 category |
| Full-feature ring alternative | RingConn Gen 2 - full feature set, no subscription of any kind | $313.99 |
| Category-benchmark alternative | Oura Ring 4 plus its app subscription at $5.99/month | $349 + $71.88/yr |
| Mid-market alternative | Renpho LYNX Smart Ring - HR, SpO2, sleep, HRV | $179.99 |
| Smartwatch alternative | Amazfit Bip 6 - smartwatch form, HR, SpO2, sleep | $80 |
| SmartLife Loyalty subscription - $718.80/yr | No subscription - every ring above except the Oura charges nothing recurring | $0 |
| Data NFT Stake Level 1 - $325 | No open-market equivalent exists; it buys no capability, only a multiplier | $0 |
| Setup fee - $20 | No equivalent | $0 |
| Total as sold $1,432.80 in year one for a typical builder |
Total, built yourself $149.99-$313.99 once, with nothing recurring |
Price-to-value
The device is not the problem and it would be dishonest to pretend otherwise: $149 matches the Amazfit Helio Ring to within a dollar, undercuts the RingConn Gen 2 by $165 and the Oura Ring 4 by $200, and carries an oximetry clearance most of the comparison set does not hold. Buy the wearable and you have bought fairly. The premium is entirely in the attachments - a $718.80-a-year subscription whose function is to keep you eligible for commission rather than to give you anything the device does not already do, and a $325-to-$3,000 stake that delivers no feature, no data and no capability at all. A buyer wanting the health-tracking function of the typical-builder year could take the RingConn Gen 2 at $313.99 and keep $1,118.81.
Three operators, five horizons
Probability of cumulative net profit
Hover any point for median, top decile and bottom quartile.
Light-tier participant
buys the $149 band, takes the $9.90 Light subscription, a $15 Basic stake, referrals only occasionally
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 5% | −$210 |
| 6 mo | 6% | −$250 |
| 1 yr | 7% | −$300 |
| 3 yr | 7% | −$560 |
| 5 yr | 7% | −$800 |
Typical builder
Smart Kit $369, Loyalty subscription to qualify, Level 1 Data NFT Stake at $325 - $1,432.80 in year one
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 3% | −$800 |
| 6 mo | 4% | −$1,100 |
| 1 yr | 5% | −$1,390 |
| 3 yr | 6% | −$3,300 |
| 5 yr | 6% | −$5,100 |
All-in on the data play
Smart Builder Pack $1,499, Pro subscription, Level 4 stake at $3,000 for the 4x multiplier - $5,697.80 in year one
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 1% | −$3,900 |
| 6 mo | 2% | −$4,800 |
| 1 yr | 3% | −$5,550 |
| 3 yr | 4% | −$11,000 |
| 5 yr | 4% | −$16,000 |
Methodology note. These are modeled outcome ranges, not claims about what anyone earned, and they carry an unusually large modeling burden because there is nothing to anchor the income side to. ANCHORED to published figures: device prices of $149, the $369 Smart Kit and $1,499 Builder Pack, the $20 setup fee, subscription tiers at $9.90, $59.90 and $99.90 a month, Data NFT Stake tiers at $15 to $3,000 with a twelve-month lock, the 10% fast-start rate, up to 20% on weaker-leg binary volume, the 10% level-one match, the $1,000 Diamond car bonus, and the modeled year-one totals of $302.80, $1,432.80 and $5,697.80. MODELED by us: every income figure and every share-in-profit percentage, because no income disclosure statement has ever been published by this company or any of its predecessors, and the trade site that publishes top-earner incomes lists this one as "N/A." Token rewards are valued at zero across all three cohorts, which is a modeling choice and should be understood as one - it is justified by a 99.5% drawdown, roughly $3,587 of global daily volume and an announced wind-down, but a reader who believes the token recovers should adjust the top column upward accordingly. The share-in-profit percentages are deliberately low because the binary pays on the weaker leg: anyone who does not build two productive legs earns no residual at all, indefinitely, regardless of personal volume. One calibration that cuts in the company’s favor and is not shown in any row above: a person who simply buys the $149 device as a customer, ignores the subscription tiers and never touches a Data NFT is not in this table at all, and does perfectly well.
Where you are actually allowed to promote this
Platform policy reads, not verifications. Check every one before you spend a dollar - enforcement changes faster than the written policy does.
Red flags and green flags
Red flags
151The operator announced on 24 July 2026 that it is shutting the rail down
2The reward multiplier is bought, not earned
3No income disclosure statement has ever been published
4A self-regulatory referral to the FTC after the company did not respond
5The fourth pivot in twelve years, with no cohort made whole
6The predecessor band’s promised sensors never shipped
7A twelve-month lock with no documented exit and no governing contract
8The token is down 99.5% and functionally unsellable
9Rewards were funded by issuance rather than out of margin
10Not one verifiable instance of anyone being paid for their health data
11The 10% fast start pays the same on a recruit as on a customer
12Filed revenue is roughly 6% of the trade estimate
13The subscription is a toll on eligibility, not a product benefit
14A ten-day refund window
15The governing agreement names the predecessor and is governed by the laws of India
Green flags
81A genuine FDA 510(k) clearance exists and is verifiable
2No regulator warning listing anywhere, in any jurisdiction
3No FTC action, no court case, no class action
4The whitepaper promises no return
5The company states plainly that it does not set the token price
6The hardware is real, shipping and competitively priced
7The affiliate agreement carries the correct recitals
8The parent files real, named financial disclosure
We would like to be wrong about this
Upward
- Publishing a dated, specific wind-down settlement: what Data NFT Stake holders get back, whether staked funds are returned, whether unpaid distributor commissions are honored, and on what timeline. Doing that fairly would be the single largest positive move available and would re-rate the terms, owner and securities dimensions together.
- Publishing an income disclosure statement with medians, modes, the percentage earning nothing and a cost-of-participation figure - the first in thirteen years - and naming one data buyer with one dated transaction and one participant payment amount, which would convert the central story from narrative into fact.
- Separating the device business from the income opportunity entirely: a $149 oximetry-cleared wearable sold at retail with no token, no NFT tier, no subscription toll and no downline is a defensible consumer product, and the company already owns the clearance to do it. Broadening the clearance to cover ECG, blood pressure or AFib - or dropping those from the marketing - plus replacing the laws-of-India legacy agreement with a jurisdiction-appropriate, token-inclusive one and a thirty-day refund window.
Downward
- A wind-down that returns nothing to Data NFT Stake holders while group value migrates to a new GPU entity and an unnamed spin-off, or evidence that participant funds moved between group entities without disclosure.
- Any securities regulator opening a file on the Data NFT Stake in any jurisdiction - the structure is exposed and nothing has happened yet - or an FTC action following the 2022 self-regulatory referral, or a fresh self-regulatory case on live claims such as "earn money continuously without actively working."
- The spin-off entity relaunching a token, an NFT tier or a staking product to the same participant base as a fifth iteration, continued use of "FDA Approval" in headlines or distributor material, or delisting of the token from its remaining venues, removing even the notional quote.
Grade is F, score 2.82. A real FDA-cleared $149 wearable, wrapped in a $718.80-a-year eligibility subscription and a tiered stake whose only function was to multiply a token claim - on a rail the operator announced it is closing seven days before this was published.
Take the good first, because there is more of it here than the grade suggests and it is all verifiable. The 510(k) clearance is genuine: K231288, applicant Vyvo Technology Corp. of Miami, Substantially Equivalent on 4 March 2024, product code DQA. That is the real Class II pathway and it is checkable in the FDA database in about thirty seconds. The hardware is real and fairly priced: $149 for a band or a ring sits within a dollar of the Amazfit Helio Ring, $165 below the RingConn Gen 2 and $200 below the Oura Ring 4, which also charges $5.99 a month that Vyvo does not. And the regulatory sheet is clean in a way that is rare in this corner of the market - no securities-regulator warning listing was located in any of nine jurisdictions searched, no FTC action, no court case, no class action, no criminal proceeding against anyone. The whitepaper guarantees no yield. The help center says plainly that the market sets the token price and the company does not. All of that is real and none of it is grudging.
The clearance does not cover what the marketing sells, and the money is not in the device. Product code DQA is pulse oximetry - blood oxygen - and nothing more. It does not cover ECG, cuffless blood pressure, atrial-fibrillation detection or bioelectrical impedance, every one of which is marketed across the range, and the May 2024 press release was headlined "Vyvo Achieves FDA Approval" when the body of the same release correctly said clearance. Meanwhile the participant economics run through the subscription and the stake, not the hardware. A typical builder pays $1,432.80 in the first year, of which $1,043.80 - 73% - is the eligibility subscription and locked token capital that buys no hardware at all. There has never been an income disclosure statement, in thirteen years across four brands, and the trade site that publishes top-earner incomes for this industry lists this company’s as "N/A." In September 2022 the industry’s own self-regulatory council asked the company to substantiate "passive income" and "$1,800 in 3 days" claims made in its name, got no reply, and referred it to the FTC - a referral, not an FTC action, and no FTC docket followed.
The part to sit with longest is the Data NFT Stake, and it has to be stated carefully because no regulator and no court anywhere has ruled on it. Here is what the company’s own two documents say when you place them side by side. Stakes are sold at $15, $325, $1,000, $2,000 and $3,000 with a twelve-month lock on the funds. Rewards come out of a pool: total tokens available divided by the community’s total Health Index points gives a per-point value, and each holder gets their points times that value times their tier multiplier - 1x, 2x, 3x, 4x. So two people wearing the same device, producing the same readings, scoring the same index, receive a fourfold difference in return, and the whole of that difference is attributable to what they paid rather than to anything they did. That is capital in against a differential return, under a lock, from a pool the operator sizes. This report does not characterise it further, and it makes no allegation of fraud. What it does record is the timing: on 24 July 2026 the operator announced the chain, the coin and the Data-NFT business are ceasing operations through an organized wind-down, and published nothing about what happens to the staked funds. A wind-down is not misconduct. It is simply where the locked money is.
Buy the wearable, decline everything attached to it
The device is the one part of this that stands up. At $149 it is priced where it should be, it holds a real oximetry clearance, and a person who buys it as a customer, ignores the subscription tiers, never enrols and never touches a Data NFT does perfectly well out of the transaction. If long-term app support after the restructuring worries you - and it is unverified either way - an Amazfit Helio Ring at $149.99 or a RingConn Gen 2 at $313.99, neither with a subscription, buys the same capability with no corporate question attached.
Before staking anything, ask for the contract that governs it
The only affiliate agreement reachable without a login names the predecessor brand, is governed by the laws of India, and does not mention tokens or NFTs at any point. No separate terms for the Data NFT Stake could be located anywhere. Ask, in writing, which document governs your stake, what the early-exit terms are, and what happens to it in the announced wind-down. If nobody can produce it, that is the answer.
Do the multiplier sum yourself before anyone explains it to you
Two tiers, same device, same readings, same Health Index - one returns 1x and the other 4x, and the only variable is the $2,675. Ask your sponsor what the extra money buys, functionally. If the honest answer is "a bigger share of the pool," you now know precisely what class of thing you are being sold and can decide on that basis.
Sell health wearables as a merchant instead
Consumer health tracking is a large, growing retail category with genuine search demand around sleep, HRV, oximetry and ring-versus-watch comparisons, and it can be sold on straightforward affiliate or retail margin against products that need no subscription toll, no rank, no downline and no staking lock. It requires no $718.80-a-year eligibility fee and it does not put your capital inside somebody else’s twelve-month lock.
Nine dimensions, weighted
Dimension profile
Further from center is better. Hover any point.
Hard caps that bind here
The lowest binding cap wins, regardless of the weighted arithmetic.
What we read
Every source below links to the document itself. Tier 1 is a primary record - the company’s own plan, policy or disclosure, a court filing, a regulator’s decision or an SEC filing. Tier 2 is a self-regulatory or secondary regulator record, tier 3 reporting or academic work, tier 4 an open-market price comparison. Where a document can be moved or withdrawn, an archived copy is linked beside it. If a link is dead when you try it, that is a correction we want.
- "Vyvo Group Restructuring 2026: Official Announcement" - corporate announcement page hosting the signed letter in eight languages
Vyvo Group restructuring announcement, 24 July 2026, signed by founder Fabio Galdi and datelined Miami - Vyvo Smart Chain, VSC Coin and the inPersona Data-NFT business to "cease operations through an organized wind-down process," SocialFi, AI and accessories spun out, group refocusing on GPU management infrastructure; no treatment of staked funds, redemption, unpaid commissions, timeline or spin-off ownership published (vyvo.com; vyvosocialfi.com/vyvo-group-restructuring-2026)
Not established by this document: The signed announcement itself is distributed only as per-language PDFs behind the announcement page; the page body reproduces none of it. Nothing on any Vyvo property addresses staked funds, redemption, unpaid distributor commissions, the wind-down timeline or the ownership of the spun-out entities.
- Vyvo corporate homepage carrying the Miami, 24 July 2026 restructuring statement
- Vyvo SocialFi homepage - full text of the founder's restructuring letter, including the closure of Vyvo Smart Chain, VSC Coin and the inPersona Data-NFT business
- Vyvo Smart Chain - "Important Notice to the Vyvo Smart Chain & inPersona Community": HealthFi and DataFi Reward Program permanently discontinued effective 23 February 2026, and the Recovery Program
- FDA 510(k) Premarket Notification K231288 - Vyvo Technology Corp., 123 NW 23rd St., Miami FL 33127; device "Vyvo"; Substantially Equivalent, decision 4 March 2024; product code DQA, 21 CFR 870.2700
FDA 510(k) database, K231288 - applicant Vyvo Technology Corp., 123 NW 23rd St., Miami FL 33127; device name Vyvo; decision Substantially Equivalent, 4 March 2024; product code DQA (Oximeter); regulation 21 CFR 870.2700
- Vyvo Smart Chain / inPersona Data NFT page - staking tiers at $15, $325, $1,000, $2,000 and $3,000, twelve-month staking period, and the level-based rewards table
inPersona help center, "What is a Data NFT Stake" - tiers at $15 / $325 / $1,000 / $2,000 / $3,000, "there is a 12-month locking period for the staked funds from the activation or Upgrade," reversion to an inactive state when staking ends, and "the only way to ensure the reception of the complete Rewards is exclusively through the store"
Not established by this document: The specific help-center article titled "What is a Data NFT Stake" is served from the inPersona/Vyvo support portal, which returns no retrievable article at that title; the Data NFT page above carries the same tier ladder and twelve-month lock language and is cited in its place.
- inPersona dApp overview - Data NFT purchase route through the inPersona store and device binding
- "$B3TR Rewards" - Vyvo Smart Chain page setting out the pooled distribution, the worked example 100,000 $B3TR / 250,000 HIS = 0.40, and the 1x/2x/3x/4x Data NFT level multipliers with the 20 × 3 = 60 example
Vyvo support center, $B3TR Rewards - pooled distribution divided by community Health Index points, worked example "100,000 $B3TR / 250,000 = 0.40," and NFT level multipliers of 1x, 2x, 3x and 4x with the worked example "20 $B3TR x 3 = 60"; and Complete guide to $VSC - "the operating entity of VSC does NOT set the value to $VSC; instead, the market dictates the price value"
- "What is Vyvo Coin ($VSC) and how can I earn it?" - Vyvo Support: $VSC and $USDV described as "non-security" utility coins; "the operating entity … does NOT give a value to $VSC, but the price or value of $VSC is given by the market"
- Vyvo Smart Chain White Paper (PDF) - genesis supply, four-year halving schedule, 20,014,165,805 $VSC cap, burn-and-mint VDC mechanism and Proof-of-Sensing rewards
- Health Index page - the 0–100 score, its three categories and weightings, feeding the $B3TR distribution
- DSSRC Case No. 79-2022 - Government Referral, Vyvo, Inc. (case page)
Direct Selling Self-Regulatory Council announcement, 1 September 2022 - referral of Vyvo, Inc. to the Federal Trade Commission for possible enforcement action following a June 2022 Notice of Inquiry, multiple further contact attempts, no response and no substantiation; claims cited include "passive income" and "($1,800) in 3 days"
- DSSRC Referral Report, Case No. 79-2022, Vyvo, Inc., filed 4 August 2022 (PDF) - Notice of Inquiry 13 June 2022, 10-day notice 7 July 2022, no response, referral to the FTC
- "Direct Selling Self-Regulatory Council Refers Vyvo Earnings Claims to the Federal Trade Commission for Possible Enforcement Action" - BBB National Programs press release, 1 September 2022, quoting the "($1,800) in 3 days" and residual-income claims
- Helo Corp. Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines - Annual Report for the period ending 31 December 2023 (86,752,302 common shares; 100 Preferred A super-voting; 2,000,000 Preferred B)
Helo Corp. Pink Basic Disclosure, year ended 31 December 2023 - continuing-operations revenue $4,553,764, discontinued $2,899,378, net income $8,783,435, total assets $28,459,255, liabilities $9,395,340, equity $19,063,915, 86,752,302 common shares outstanding; insider holdings including Fabio Galdi 20.4% and Sean McVeigh with 16 of 100 Preferred A super-voting shares
- Helo Corp. (HLOC) disclosure filings index on OTC Markets
- "Helo Corp Announces Annual 2023 Results" - company press release confirming continuing-operations revenue of $4,553,764, discontinued revenue of $2,899,378 and net income of $8,783,435, and attributing the net income to a $15.2m increase in the fair value of locked VSC Coins
- "Vyvo Review: World Global Network's unbelievably messy reboot" - BehindMLM plan analysis: 100 PV qualification, 10% Fast Start, up to 20% weaker-leg binary with weekly carry-forward, 25% residual for twelve months, matching bonus
BehindMLM review of the plan materials and brand lineage - 10% Fast Start paid on sales to retail customers or recruited affiliates, weaker-leg percentage binary up to 20% with weekly carry-forward, 25% residual rate for twelve months tied to recruitment, matching bonus ladder across eleven ranks, $1,000 Diamond car bonus, 100 SV qualification, subscription tiers, pack pricing, and the Q4 2022 announcement that Helo Corp would abandon the Vyvo MLM opportunity
- "Helo Corp announces plans to abandon Vyvo MLM opportunity" - BehindMLM report on the Q4 2022 announcement
- VYVO company profile - Business For Home: estimated revenue flat at $70 million 2021–2025, estimated commission payout ~$28 million a year, Business Grade A+
BusinessForHome company profile - revenue estimated flat at $70 million for 2021 through 2025, commission payout estimated at 40% of revenue (~$28 million), top-earner figures listed as "N/A," one recommended distributor on file. A trade-publication estimate, not a company figure
- Vyvo Smart Chain (VSC) price, market cap and volume - CoinGecko
CoinGecko and CoinMarketCap pages for the token, fetched 31 July 2026 - price around $0.0003897, market cap $1,833,794, 24-hour volume $3,587.15 with about $2,160 on a single venue, all-time high $0.07558 on 30 December 2023, down 99.5%; mainnet 14 December 2022; 1.2 billion minted annually against a cap near 20.1 billion. One aggregator now renders as a preview showing $0.00
- Vyvo Coin (VSC) price, supply schedule and mainnet date - CoinMarketCap (mainnet 14 December 2022; 1.2bn minted annually; max supply 20,101,648,050 VSC)
- Vyvo affiliate agreement served in the member store - counterparty World Global Network, governed by the laws of India, ten-day refund window, termination at any time for any cause, no mention of tokens or NFTs
Affiliate agreement served at my.vyvo.com/store/document/3/101 - named counterparty World Global Network, "this Agreement shall be governed by the laws of India," commissions from product sales not sponsoring, no guaranteed earnings, termination "at any time for any cause or reason," refunds within "10 (ten) days from the date of activation," no arbitration clause, no mention of tokens or NFTs; plus product pricing from shop.helohealth.com and the Vyvo wearables, band and watch pages, and consumer smart-ring retail pricing from Wareable and Engadget round-ups
Not established by this document: The Helo Health store renders product pages without prices to a fetcher (prices load behind the cart/regional selector), so the wearable, band and watch retail figures could not be re-verified from the company's own storefront. The Engadget smart-ring round-up named in the prose was not located; the Wareable round-up is cited alone as the open-market comparison.
- Helo Health store - BioSense Health Band, LifeWatch Generation 2, LifeWatch Lite SE, Smart Scale and Leggera 2 product pages
- "Best smart rings 2026: Oura and top alternatives tested" - consumer smart-ring retail pricing benchmark (Oura Ring 4 from $349 plus $5.99/month; RingConn Gen 2 $313.99; RingConn Gen 2 Air $199; Renpho LYNX $179.99; Amazfit Helio $149.99)
What we could not get
- The weekly binary earnings cap. No figure is published in any obtainable document, which is the single most consequential omission in the plan - every credible binary publishes a per-position weekly ceiling, and without it a participant cannot model their own maximum. The residual rate ladder by rank, the rank qualification volumes for all eleven ranks, whether stronger-leg volume ever flushes, and the official compensation plan document itself are all equally unobtainable; the back office requires a login.
- Any contractual terms governing the Data NFT Stake. No terms and conditions, no early-exit provision, no penalty schedule and no governing document of any kind could be located, and the only reachable affiliate agreement does not mention tokens or NFTs at any point. Someone who paid $3,000 has no findable contract covering what they bought.
- What happens to staked funds after the 24 July 2026 wind-down announcement - redemption, refund, forfeiture or otherwise - along with the wind-down timeline, the treatment of unpaid distributor commissions, and the name, ownership and jurisdiction of the spin-off entity. None of it is published anywhere.
- Any regulator warning, alert, advisory, cease-and-desist or enforcement action in any jurisdiction. This one is published as a finding rather than a gap: none was located against Vyvo, Vyvo Smart Chain, inPersona, Helo Corp or World Global Network at Belgium FSMA, Italy CONSOB, Spain CNMV, France AMF, the Canadian commissions, New Zealand FMA, the Philippines SEC, US state securities regulators or the US SEC. The honest caveats are that these were searched through public web indexes rather than each regulator’s internal database, and that non-English-language actions are under-represented in that corpus. Absence of an action is not a clearance - but it is a genuinely favorable fact and it is reported as one.
- Any data sale, any named data buyer, or any participant payment for health data. Data monetisation has been the differentiating story since 2022 and the whitepaper names pharmaceutical companies, universities, hospitals and research centers as target buyers, but across the whitepaper, both help centers, the press releases and the parent’s filings there is not one named counterparty, one completed transaction, one dated payment or one dollar amount. The parent’s filed FY2023 revenue carries no line item attributable to data sales.
- CE marking status for any Vyvo device. No CE claim appears on any reachable product page, and no marking could be confirmed. Equally, no FDA clearance covering ECG, cuffless blood pressure, atrial-fibrillation detection or bioelectrical impedance on any device could be located - only K231288, which covers oximetry.
- Whether any compensation was paid to participants at any of the four brand transitions since 2013, and the outcome of the 2022 self-regulatory referral to the FTC. No compensation record and no FTC docket, complaint or action could be located in either case.
- Current pricing for the DNA kit, the stickers, the larger device, the Smart Kit and the Builder Pack - the figures used here are from a 2020-era extraction. The BioSense Watch price is not published at all and the company store renders client-side. Also unverified: whether the app and device support continue after the restructuring, the composition of the parent’s $10.4 million continuing-operations net income on $4.55 million of revenue, and consolidated group revenue, since the Singapore and Utah operating companies do not publish.
Not advice
This is independent analysis for decision-making, not legal, financial or investment advice. Allegations reported by third parties should be verified against primary court and regulatory records before any decision.
Researched by Claude. Reviewed by an editor.
Every report is researched and written by Claude, Anthropic’s AI assistant, from the company’s own plan documents, policies, terms and regulatory file - then reviewed before publication by Rob Fore, who checks the sources and the stage-label on every allegation.
- Nine weighted dimensions, published with their weights
- The editor checks the evidence and cannot change the number - the build rejects any page whose grade does not reconcile to its own arithmetic
- Every affiliate position we hold is disclosed on the report it touches
- No company has paid for a grade, and no report carries an affiliate link
Looking at something else?
Enter any company name or website. If a report exists it opens instantly; if not, we start one.
Vyvo - frequently asked
QIs Vyvo a scam?
QIs the Vyvo FDA clearance real?
QWhat is a Data NFT Stake and how does the multiplier work?
QWhat happens to my money now that Vyvo is winding the chain down?
QIs the $149 BioSense device worth buying?
Author, editor and publisher
This report was researched and written by Claude, Anthropic’s AI assistant, working from primary documents - Vyvo’s own compensation plan, its policies and procedures, its terms of service, its income disclosure statement where one exists, and its regulatory and self-regulatory file. It was scored against nine weighted dimensions that are published in full, with their weights, on the methodology page.
Before publication it was reviewed by Rob Fore, who checks every source link, every figure against the document it came from, and every allegation against its stage-label - an investigation is not a finding, a warning letter is not an enforcement action, and a filed claim is not a verdict.
The editor does not set the grade. The published score is the weighted composite of the nine dimension scores, and the build refuses to emit a page where the two disagree by more than 0.06. A grade moves when the evidence moves it and not otherwise.
Rob Fore has marketed online since 1996, wrote Online MLM Marketing (2014), and is CEO of Listech Inc, the Nevada corporation that publishes this site. He holds affiliate positions in companies graded here - including LiveGood, which this site grades D, SendOutCards, which it grades C−, and the Home Business Academy, which it grades B−. Those positions are disclosed on the reports they touch, and changed nothing on this page.
About the author and our conflicts · Contact the editor · Corrections: corrections@opportunitygrade.com
Tell me if this grade changes
Vyvo is graded F as of July 31, 2026. Grades move when the evidence moves - a new income disclosure, a regulatory action, a rewritten compensation plan. Leave your address and you will get one email if this one does.
One email when the grade moves, and nothing else. We will never use your address to promote an income opportunity of any kind, we do not sell, rent or share the list, and it is stored on our own infrastructure rather than with any company graded here. Unsubscribe removes everything.
Corrections
Every factual claim on this page is sourced, and the ones we could not stand up are named in the unable to verify list above. If something here is wrong, we want to know, and we would rather hear it from Vyvo than from a reader.
Write to corrections@opportunitygrade.com. Point at the specific sentence and send the document that contradicts it - a plan document, a filing, an income disclosure, a policy page. We will check it against the primary source, correct the page if it is wrong, and say in the report that it was corrected and when. A grade moves if the evidence moves it.
This address reaches a person, not a form. We do not require a takedown demand, an NDA or a lawyer to accept a correction, and we do not remove a report because a company disputes its conclusion - only because the underlying facts turn out to be wrong.